Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.

Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, Balakrishnan P, Yepthomi T, Poongulali S, Flanigan TP, Solomon S, Mayer KH.

AIDS Patient Care STDS. 2008 Apr;22(4):337-44. doi: 10.1089/apc.2007.0093.

PMID:
18422462
2.

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004535. Review.

PMID:
16625606
3.

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.

Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD008270. doi: 10.1002/14651858.CD008270.pub2. Review.

PMID:
23740608
5.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
6.

Toxicity of non-nucleoside analogue reverse transcriptase inhibitors.

Kontorinis N, Dieterich DT.

Semin Liver Dis. 2003 May;23(2):173-82. Review.

PMID:
12800070
7.

Adverse effects of antiretroviral therapy for HIV infection.

Montessori V, Press N, Harris M, Akagi L, Montaner JS.

CMAJ. 2004 Jan 20;170(2):229-38. Review.

8.

Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.

Núñez M.

Hepatology. 2010 Sep;52(3):1143-55. doi: 10.1002/hep.23716. Review.

PMID:
20812358
9.

Highly active antiretroviral therapy-induced liver injury.

Inductivo-Yu I, Bonacini M.

Curr Drug Saf. 2008 Jan;3(1):4-13. Review.

PMID:
18690975
10.

Sweetening the toxic cocktail. Managing the side effects of HIV medications.

Doerfler RE.

Adv Nurse Pract. 2002 May;10(5):52-4, 57-8, 103. Review. No abstract available.

PMID:
12420531
11.

The problems faced when assessing the prevalence and incidence of antiretroviral-related toxicities.

Smith CJ, Sabin CA.

Antivir Ther. 2004 Dec;9(6):865-78. Review.

PMID:
15651745

Supplemental Content

Support Center